Gene · 7130
Papers2,523
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 2,523
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pan-Cancer Analysis of Pentraxin 3: A Potential Biomarker of COVID-19. | Cancers (Basel) | 2022 | 36139597 | PubTator, text mining | PubMed |
| Therapeutic Benefits of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome: Potential Mechanisms and Challenges. | J Inflamm Res | 2022 | 36120184 | PubTator, text mining | PubMed |
| High-throughput sequencing unravels the cell heterogeneity of cerebrospinal fluid in the bacterial meningitis of children. | Front Immunol | 2022 | 36119025 | PubTator, text mining | PubMed |
| Identifying hub genes and miRNAs in Crohn's disease by bioinformatics analysis. | Front Genet | 2022 | 36118873 | PubTator, text mining | PubMed |
| [Expression of TNFAIP6 in oral verrucous carcinoma and oral squamous cell carcinoma and its relationship with clinicopathology]. | Shanghai Kou Qiang Yi Xue | 2022 | 36110074 | PubTator, text mining | PubMed |
| NcRNA-mediated upregulation of CAMK2N1 is associated with poor prognosis and tumor immune infiltration of gastric cancer. | Front Genet | 2022 | 36092901 | PubTator, text mining | PubMed |
| Extracellular Vesicles: The Next Generation Theranostic Nanomedicine for Inflammatory Bowel Disease. | Int J Nanomedicine | 2022 | 36092245 | PubTator, text mining | PubMed |
| Hyaluronic Acid: A Review of the Drug Delivery Capabilities of This Naturally Occurring Polysaccharide. | Polymers (Basel) | 2022 | 36080515 | PubTator, text mining | PubMed |
| Headway and the remaining hurdles of mesenchymal stem cells therapy for bronchopulmonary dysplasia. | Clin Respir J | 2022 | 36055758 | PubTator, text mining | PubMed |
| Comparison of EV-free fraction, EVs, and total secretome of amniotic mesenchymal stromal cells for their immunomodulatory potential: a translational perspective. | Front Immunol | 2022 | 36052081 | PubTator, text mining | PubMed |
| Disease- and headache-specific microRNA signatures and their predicted mRNA targets in peripheral blood mononuclear cells in migraineurs: role of inflammatory signalling and oxidative stress. | J Headache Pain | 2022 | 36050647 | PubTator, text mining | PubMed |
| Dynamic Culture of Mesenchymal Stromal/Stem Cell Spheroids and Secretion of Paracrine Factors. | Front Bioeng Biotechnol | 2022 | 36046670 | PubTator, text mining | PubMed |
| Network pharmacological analysis of active components of Xiaoliu decoction in the treatment of glioblastoma multiforme. | Front Genet | 2022 | 36046228 | PubTator, text mining | PubMed |
| Advances in mesenchymal stromal cell therapy for acute lung injury/acute respiratory distress syndrome. | Front Cell Dev Biol | 2022 | 36036014 | PubTator, text mining | PubMed |
| Interleukin-1β in tendon injury enhances reparative gene and protein expression in mesenchymal stem cells. | Front Vet Sci | 2022 | 36032300 | PubTator, text mining | PubMed |
| Cellular transcriptional alterations of peripheral blood in Alzheimer's disease. | BMC Med | 2022 | 36031604 | PubTator, text mining | PubMed |
| A top-down approach to uncover the hidden ligandome of low-density lipoprotein receptor-related protein 1 in cartilage. | Matrix Biol | 2022 | 36028175 | PubTator, text mining | PubMed |
| Meta-Data Analysis to Explore the Hub of the Hub-Genes That Influence SARS-CoV-2 Infections Highlighting Their Pathogenetic Processes and Drugs Repurposing. | Vaccines (Basel) | 2022 | 36016137 | PubTator, text mining | PubMed |
| -Omic Approaches and Treatment Response in Rheumatoid Arthritis. | Pharmaceutics | 2022 | 36015273 | PubTator, text mining | PubMed |
| Pathophysiology of Sepsis and Genesis of Septic Shock: The Critical Role of Mesenchymal Stem Cells (MSCs). | Int J Mol Sci | 2022 | 36012544 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7130/papers?page=29